| Q8V | 表記: | ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate | 組成式: | C12 H12 N2 O2 | SMILES: | c1cc(C(=C(C(OCC)=O)C#N)N)ccc1 | InChi: | InChI=1S/C12H12N2O2/c1-2-16-12(15)10(8-13)11(14)9-6-4-3-5-7-9/h3-7H,2,14H2,1H3/b11-10- | 別名: | phenamacril | 定義日: | 2019-10-03 | 最終更新日: | 2021-03-01 | 公開日: | 2020-03-25 | 識別子(ID): | ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate |
|
| OMD | 表記: | 2-(3,6-DIHYDROXYPHENYL)ACETIC ACID | 組成式: | C8 H8 O4 | SMILES: | O=C(O)Cc1cc(O)ccc1O | InChi: | InChI=1S/C8H8O4/c9-6-1-2-7(10)5(3-6)4-8(11)12/h1-3,9-10H,4H2,(H,11,12) | 別名: | HOMOGENTISIC ACID | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2,5-dihydroxyphenyl)acetic acid |
|
| HL0 | 表記: | N-[(3S)-2-oxotetrahydrofuran-3-yl]decanamide | 組成式: | C14 H25 N O3 | SMILES: | O=C1OCCC1NC(=O)CCCCCCCCC | InChi: | InChI=1S/C14H25NO3/c1-2-3-4-5-6-7-8-9-13(16)15-12-10-11-18-14(12)17/h12H,2-11H2,1H3,(H,15,16)/t12-/m0/s1 | 別名: | N-decanoyl-L-homoserine lactone | 定義日: | 2011-02-15 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-[(3S)-2-oxotetrahydrofuran-3-yl]decanamide |
|
| TWO | 表記: | 3,4-dimethoxybenzoic acid | 組成式: | C9 H10 O4 | SMILES: | O=C(O)c1cc(OC)c(OC)cc1 | InChi: | InChI=1S/C9H10O4/c1-12-7-4-3-6(9(10)11)5-8(7)13-2/h3-5H,1-2H3,(H,10,11) | 別名: | VERATRIC ACID | 定義日: | 2012-04-09 | 最終更新日: | 2021-03-01 | 公開日: | 2013-02-15 | 識別子(ID): | 3,4-dimethoxybenzoic acid |
|
| 0NQ | 表記: | N-{(1S)-3-[(5S)-5-tert-butyl-1-(3,3-dimethylbutyl)-4-hydroxy-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-1-ethoxy-1-oxido-1,4-dihydro-2,4,1-benzodiazaphosphinin-7-yl}methanesulfonamide | 組成式: | C24 H37 N4 O6 P S | SMILES: | O=S(=O)(Nc1ccc2c(c1)P(=O)(N=C(N2)C3=C(O)C(N(C3=O)CCC(C)(C)C)C(C)(C)C)OCC)C | InChi: | InChI=1S/C24H37N4O6PS/c1-9-34-35(31)17-14-15(27-36(8,32)33)10-11-16(17)25-21(26-35)18-19(29)20(24(5,6)7)28(22(18)30)13-12-23(2,3)4/h10-11,14,20,27,29H,9,12-13H2,1-8H3,(H,25,26,31)/t20-,35+/m1/s1 | 別名: | IDX375 | 定義日: | 2012-03-23 | 最終更新日: | 2021-03-01 | 公開日: | 2013-03-27 | 識別子(ID): | N-{(1S)-3-[(5S)-5-tert-butyl-1-(3,3-dimethylbutyl)-4-hydroxy-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-1-ethoxy-1-oxido-1,4-dihydro-2,4,1-benzodiazaphosphinin-7-yl}methanesulfonamide |
|
| 0OD | 表記: | trichloro{(1,2,3,4,5-eta)-1,2,3,4-tetramethyl-5-[2-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}amino)ethyl]cyclopentadienyl}rhodium(1+) | 組成式: | C21 H32 Cl3 N3 O2 Rh S | SMILES: | O=C1NC2C(SCC2N1)CCCCC(=O)NCCc37c4(C)c5(C)c6(C)C3(C)[Rh+]4567(Cl)(Cl)Cl | InChi: | InChI=1S/C21H32N3O2S.3ClH.Rh/c1-12-13(2)15(4)16(14(12)3)9-10-22-19(25)8-6-5-7-18-20-17(11-27-18)23-21(26)24-20 | 別名: | [Cp*(Biot-methylene)RhCl(H2O)2]+ | 定義日: | 2012-08-21 | 最終更新日: | 2021-03-01 | 公開日: | 2013-02-08 | 識別子(ID): | trichloro{(1,2,3,4,5-eta)-1,2,3,4-tetramethyl-5-[2-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}amino)ethyl]cyclopentadienyl}rhodium(1+) |
|
| HLW | 表記: | 3-(3-chlorophenyl)-N-{2-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]ethyl}propan-1-amine | 組成式: | C18 H20 Cl N5 | SMILES: | Clc1cccc(c1)CCCNCCc2nc(ncc2)n3ccnc3 | InChi: | InChI=1S/C18H20ClN5/c19-16-5-1-3-15(13-16)4-2-8-20-9-6-17-7-10-22-18(23-17)24-12-11-21-14-24/h1,3,5,7,10-14,20H,2,4,6,8-9H2 | 別名: | N-2-(2-(1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL)ETHYL-3-(3-CHLOROPHENYL)PROPAN-1-AMINE | 定義日: | 2014-10-21 | 最終更新日: | 2021-03-01 | 公開日: | 2014-12-24 | 識別子(ID): | 3-(3-chlorophenyl)-N-{2-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]ethyl}propan-1-amine |
|
| 0OM | 表記: | benzyl pyridine-3-carboxylate | 組成式: | C13 H11 N O2 | SMILES: | O=C(OCc1ccccc1)c2cccnc2 | InChi: | InChI=1S/C13H11NO2/c15-13(12-7-4-8-14-9-12)16-10-11-5-2-1-3-6-11/h1-9H,10H2 | 別名: | Benzyl nicotinate | 定義日: | 2012-04-03 | 最終更新日: | 2021-03-01 | 公開日: | 2012-11-30 | 識別子(ID): | benzyl pyridine-3-carboxylate |
|
| 0ON | 表記: | N-phenylpyridine-3-carboxamide | 組成式: | C12 H10 N2 O | SMILES: | O=C(Nc1ccccc1)c2cccnc2 | InChi: | InChI=1S/C12H10N2O/c15-12(10-5-4-8-13-9-10)14-11-6-2-1-3-7-11/h1-9H,(H,14,15) | 別名: | N-phenylnicotinamide | 定義日: | 2012-04-03 | 最終更新日: | 2021-03-01 | 公開日: | 2012-11-30 | 識別子(ID): | N-phenylpyridine-3-carboxamide |
|
| HM6 | 表記: | 4-(4-(hydroxymethyl)-1h-1,2,3-triazol-1-yl)pyridine-2,6-dicarboxylic acid | 組成式: | C10 H8 N4 O5 | SMILES: | O=C(O)c1nc(cc(c1)n2nnc(c2)CO)C(=O)O | InChi: | InChI=1S/C10H8N4O5/c15-4-5-3-14(13-12-5)6-1-7(9(16)17)11-8(2-6)10(18)19/h1-3,15H,4H2,(H,16,17)(H,18,19) | 別名: | HYDROXYMETHYLTRIAZOLE DIPICOLINIC ACID | 定義日: | 2012-09-13 | 最終更新日: | 2021-03-01 | 公開日: | 2012-11-09 | 識別子(ID): | 4-[4-(hydroxymethyl)-1H-1,2,3-triazol-1-yl]pyridine-2,6-dicarboxylic acid |
|
| HMG | 表記: | 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A | 組成式: | C27 H39 N7 O20 P3 S | SMILES: | [O-]C(=O)CC(O)(C)CC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP([O-])(=O)OP([O-])(=O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3OP([O-])([O-])=O | InChi: | InChI=1S/C27H44N7O20P3S/c1-26(2,21(40)24(41)30-5-4-15(35)29-6-7-58-17(38)9-27(3,42)8-16(36)37)11-51-57(48,49)54-56(46,47)50-10-14-20(53-55(43,44)45)19(39)25(52-14)34-13-33-18-22(28)31-12-32-23(18)34/h12-14,19-21,25,39-40,42H,4-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,46,47)(H,48,49)(H2,28,31,32)(H2,43,44,45)/p-5/t14-,19-,20-,21+,25-,27+/m1/s1 | 別名: | (S)-HMG-COA | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (9R,21S)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonatooxy)tetrahydrofuran-2-yl]-9,21-dihydroxy-8,8,21-trimethyl-3,5-dioxido-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphatricosan-23-oate 3,5-dioxide (non-preferred name) |
|
| 0PC | 表記: | Nalpha-[(benzyloxy)carbonyl]-N-[(1S)-3-chloro-1-methyl-2-oxopropyl]-L-phenylalaninamide | 組成式: | C21 H23 Cl N2 O4 | SMILES: | ClCC(=O)C(NC(=O)C(NC(=O)OCc1ccccc1)Cc2ccccc2)C | InChi: | InChI=1S/C21H23ClN2O4/c1-15(19(25)13-22)23-20(26)18(12-16-8-4-2-5-9-16)24-21(27)28-14-17-10-6-3-7-11-17/h2-11,15,18H,12-14H2,1H3,(H,23,26)(H,24,27)/t15-,18-/m0/s1 | 別名: | ZPACK | 定義日: | 2008-09-14 | 最終更新日: | 2021-03-01 | 識別子(ID): | Nalpha-[(benzyloxy)carbonyl]-N-[(2S)-4-chloro-3-oxobutan-2-yl]-L-phenylalaninamide |
|
| 0PR | 表記: | N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-L-tyrosine | 組成式: | C17 H21 N2 O8 P | SMILES: | O=C(O)C(NCc1c(cnc(c1O)C)COP(=O)(O)O)Cc2ccc(O)cc2 | InChi: | InChI=1S/C17H21N2O8P/c1-10-16(21)14(12(7-18-10)9-27-28(24,25)26)8-19-15(17(22)23)6-11-2-4-13(20)5-3-11/h2-5,7,15,19-21H,6,8-9H2,1H3,(H,22,23)(H2,24,25,26)/t15-/m0/s1 | 別名: | PHOSPHO-5'-PYRIDOXYL TYROSINE | 定義日: | 2008-11-10 | 最終更新日: | 2021-03-01 | 公開日: | 2018-09-19 | 識別子(ID): | N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-L-tyrosine |
|
| 0Q4 | 表記: | N-[(2R)-2-({N~5~-[amino(iminio)methyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucinamide | 組成式: | C40 H70 N11 O8 | SMILES: | O=C(N)C(NC(=O)C(NC(=O)C(NC(=O)C(NCC(NC(=O)C(NC(=O)C(N)CCCNC(=[NH2+])N)C(C)C)CC(C)C)Cc1ccccc1)CCC(=O)O)C)CCCC | InChi: | InChI=1S/C40H69N11O8/c1-7-8-16-29(34(42)54)49-35(55)25(6)47-37(57)30(17-18-32(52)53)50-38(58)31(21-26-13-10-9-11-14-26)46-22-27(20-23(2)3)48-39(59)33(24(4)5)51-36(56)28(41)15-12-19-45-40(43)44/h9-11,13-14,23-25,27-31,33,46H,7-8,12,15-22,41H2,1-6H3,(H2,42,54)(H,47,57)(H,48,59)(H,49,55)(H,50,58)(H,51,56)(H,52,53)(H4,43,44,45)/p+1/t25-,27-,28-,29-,30-,31-,33-/m0/s1 | 別名: | Inhibitor analogues of CA-p2 | 定義日: | 2008-09-14 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-[(2S)-2-({N~5~-[amino(iminio)methyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucinamide |
|
| 0QB | 表記: | (2S)-2-[(2-amino-1,3-thiazol-4-yl)methyl]-N~1~-{(1S,2S)-1-(cyclohexylmethyl)-2-hydroxy-2-[(3R)-1,5,5-trimethyl-2-oxopyrrolidin-3-yl]ethyl}-N~4~-[2-(dimethylamino)-2-oxoethyl]-N~4~-[(1S)-1-phenylethyl]butanediamide | 組成式: | C36 H54 N6 O5 S | SMILES: | O=C1N(C)C(C)(C)CC1C(O)C(NC(=O)C(Cc2nc(sc2)N)CC(=O)N(CC(=O)N(C)C)C(c3ccccc3)C)CC4CCCCC4 | InChi: | InChI=1S/C36H54N6O5S/c1-23(25-15-11-8-12-16-25)42(21-31(44)40(4)5)30(43)19-26(18-27-22-48-35(37)38-27)33(46)39-29(17-24-13-9-7-10-14-24)32(45)28-20-36(2,3)41(6)34(28)47/h8,11-12,15-16,22-24,26,28-29,32,45H,7,9-10,13-14,17-21H2,1-6H3,(H2,37,38)(H,39,46)/t23-,26+,28-,29-,32-/m0/s1 | 別名: | P2-P3 butanediamide renin inhibitor (3) | 定義日: | 2008-11-12 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S)-2-[(2-amino-1,3-thiazol-4-yl)methyl]-N~1~-{(1S,2S)-1-(cyclohexylmethyl)-2-hydroxy-2-[(3R)-1,5,5-trimethyl-2-oxopyrrolidin-3-yl]ethyl}-N~4~-[2-(dimethylamino)-2-oxoethyl]-N~4~-[(1S)-1-phenylethyl]butanediamide |
|
| 0QL | 表記: | 3-[(2-aminoethyl)disulfanyl]-L-alanine | 組成式: | C5 H12 N2 O2 S2 | SMILES: | O=C(O)C(N)CSSCCN | InChi: | InChI=1S/C5H12N2O2S2/c6-1-2-10-11-3-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1 | 別名: | CYS-MTSEA | 定義日: | 2012-04-16 | 最終更新日: | 2021-03-01 | 識別子(ID): | 3-[(2-aminoethyl)disulfanyl]-L-alanine |
|
| HNF | 表記: | 7-nitro-9H-fluoren-2-ol | 組成式: | C13 H9 N O3 | SMILES: | Oc1ccc2c(Cc3cc(ccc23)[N+]([O-])=O)c1 | InChi: | InChI=1S/C13H9NO3/c15-11-2-4-13-9(7-11)5-8-6-10(14(16)17)1-3-12(8)13/h1-4,6-7,15H,5H2 | 別名: | 2-hydroxy-7-nitrofluorene | 定義日: | 2009-03-27 | 最終更新日: | 2021-03-01 | 識別子(ID): | 7-nitro-9H-fluoren-2-ol |
|
| HNJ | 表記: | 3-{[2-(pyrrolidin-1-yl)phenyl]amino}-1H-1lambda~6~,2-benzothiazole-1,1-dione | 組成式: | C17 H17 N3 O2 S | SMILES: | C1CN(CC1)c2c(cccc2)NC=4c3c(cccc3)S(=O)(=O)N=4 | InChi: | InChI=1S/C17H17N3O2S/c21-23(22)16-10-4-1-7-13(16)17(19-23)18-14-8-2-3-9-15(14)20-11-5-6-12-20/h1-4,7-10H,5-6,11-12H2,(H,18,19) | 別名: | (3-Chloro-Phenyl)-acetic acid (S)-1-(2-tert-butoxycarbonylamino-acetyl)-pyrrolidin-2-ylmethyl ester | 定義日: | 2018-07-16 | 最終更新日: | 2021-03-01 | 公開日: | 2019-02-13 | 識別子(ID): | 3-{[2-(pyrrolidin-1-yl)phenyl]amino}-1H-1lambda~6~,2-benzothiazole-1,1-dione |
|
| 0RQ | 表記: | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3R)-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-4-[[3-oxidanylidene-3-(4-oxidanylidenepentylamino)propyl]amino]butyl] hydrogen phosphate | 組成式: | C24 H40 N7 O17 P3 | SMILES: | O=C(C)CCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3OP(=O)(O)O | InChi: | InChI=1S/C24H40N7O17P3/c1-13(32)5-4-7-26-15(33)6-8-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-14-18(47-49(37,38)39)17(34)23(46-14)31-12-30-16-20(25)28-11-29-21(16)31/h11-12,14,17-19,23,34-35H,4-10H2,1-3H3,(H,26,33)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/t14-,17-,18-,19+,23-/m1/s1 | 別名: | dethiaacetyl-coenzyme A | 定義日: | 2012-05-06 | 最終更新日: | 2021-03-01 | 公開日: | 2012-10-05 | 識別子(ID): | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]methyl (3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(4-oxopentyl)amino]propyl}amino)butyl dihydrogen diphosphate (non-preferred name) |
|
| HOE | 表記: | 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | 組成式: | C25 H25 N6 O | SMILES: | Oc1ccc(cc1)c3nc2ccc(cc2n3)c6nc4c(cc(cc4)N5CC[NH+](CC5)C)n6 | InChi: | InChI=1S/C25H24N6O/c1-30-10-12-31(13-11-30)18-5-9-21-23(15-18)29-25(27-21)17-4-8-20-22(14-17)28-24(26-20)16-2-6-19(32)7-3-16/h2-9,14-15,32H,10-13H2,1H3,(H,26,28)(H,27,29)/p+1 | 別名: | HOECHST 33258 | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | 4-[2'-(4-hydroxyphenyl)-1H,3'H-2,5'-bibenzimidazol-6-yl]-1-methylpiperazin-1-ium |
|
| HOP | 表記: | (1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL | 組成式: | C23 H27 N O4 | SMILES: | O=C(O)CCCNC(=O)c1ccc(cc1)C3CCC(c2ccccc2)CC3O | InChi: | InChI=1S/C23H27NO4/c25-21-15-19(16-5-2-1-3-6-16)12-13-20(21)17-8-10-18(11-9-17)23(28)24-14-4-7-22(26)27/h1-3,5-6,8-11,19-21,25H,4,7,12-15H2,(H,24,28)(H,26,27)/t19-,20+,21-/m0/s1 | 別名: | OXY-COPE-HAPTEN | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | 4-[({4-[(1R,2S,4S)-2-hydroxy-4-phenylcyclohexyl]phenyl}carbonyl)amino]butanoic acid |
|
| HP1 | 表記: | ~{N}-[5-[[5-[[5-[[3-[3-(dimethylamino)propylamino]-3-oxidanylidene-propyl]carbamoyl]-1-methyl-pyrrol-3-yl]carbamoyl]-1-methyl-pyrrol-3-yl]carbamoyl]-1-methyl-4-oxidanyl-pyrrol-3-yl]-1-methyl-imidazole-2-carboxamide | 組成式: | C31 H41 N11 O6 | SMILES: | CN(C)CCCNC(=O)CCNC(=O)c1cc(NC(=O)c2cc(NC(=O)c3n(C)cc(NC(=O)c4nccn4C)c3O)cn2C)cn1C | InChi: | InChI=1S/C31H41N11O6/c1-38(2)12-7-9-32-24(43)8-10-34-28(45)22-14-19(16-40(22)4)35-29(46)23-15-20(17-41(23)5)36-30(47)25-26(44)21(18-42(25)6)37-31(48)27-33-11-13-39(27)3/h11,13-18,44H,7-10,12H2,1-6H3,(H,32,43)(H,34,45)(H,35,46)(H,36,47)(H,37,48) | 別名: | IMIDAZOLE-HYDROXYPYRROLE-PYRROLE-PYRROLE-BETA ALANINE-DIMETHYLAMINO PROPYLAMIDE | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | ~{N}-[5-[[5-[[5-[[3-[3-(dimethylamino)propylamino]-3-oxidanylidene-propyl]carbamoyl]-1-methyl-pyrrol-3-yl]carbamoyl]-1-methyl-pyrrol-3-yl]carbamoyl]-1-methyl-4-oxidanyl-pyrrol-3-yl]-1-methyl-imidazole-2-carboxamide |
|
| 0T3 | 表記: | 4-[(5R)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl]benzonitrile | 組成式: | C14 H13 N3 | SMILES: | N#Cc1ccc(cc1)C3n2cncc2CCC3 | InChi: | InChI=1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2/t14-/m1/s1 | 別名: | fadrozole | 定義日: | 2012-05-30 | 最終更新日: | 2021-03-01 | 公開日: | 2013-01-25 | 識別子(ID): | 4-[(5R)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl]benzonitrile |
|
| HPS | 表記: | PHENYL DIHYDROGEN PHOSPHATE | 組成式: | C6 H7 O4 P | SMILES: | O=P(Oc1ccccc1)(O)O | InChi: | InChI=1S/C6H7O4P/c7-11(8,9)10-6-4-2-1-3-5-6/h1-5H,(H2,7,8,9) | 別名: | PHENYLPHOSPHATE | 定義日: | 2003-06-20 | 最終更新日: | 2021-03-01 | 識別子(ID): | phenyl dihydrogen phosphate |
|
| 0TK | 表記: | (2R)-2,5-diaminopentanoyl dihydrogen phosphate | 組成式: | C5 H13 N2 O5 P | SMILES: | O=P(OC(=O)C(N)CCCN)(O)O | InChi: | InChI=1S/C5H13N2O5P/c6-3-1-2-4(7)5(8)12-13(9,10)11/h4H,1-3,6-7H2,(H2,9,10,11)/t4-/m1/s1 | 別名: | phosphorylated D-ornithine | 定義日: | 2012-06-06 | 最終更新日: | 2021-03-01 | 公開日: | 2012-09-14 | 識別子(ID): | (2R)-2,5-diaminopentanoyl dihydrogen phosphate |
|